PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Statistics

Total Valuation

IDX:MEDS has a market cap or net worth of IDR 112.50 billion. The enterprise value is 119.05 billion.

Market Cap	112.50B
Enterprise Value	119.05B

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

IDX:MEDS has 1.56 billion shares outstanding.

Current Share Class	1.56B
Shares Outstanding	1.56B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	63.11%
Owned by Institutions (%)	n/a
Float	576.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.55
PB Ratio	2.21
P/TBV Ratio	2.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.62
EV / Sales	25.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-36.07

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 0.14.

Current Ratio	2.48
Quick Ratio	0.60
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	-2.16
Interest Coverage	-16.33

Financial Efficiency

Return on equity (ROE) is -15.82% and return on invested capital (ROIC) is -15.53%.

Return on Equity (ROE)	-15.82%
Return on Assets (ROA)	-8.77%
Return on Invested Capital (ROIC)	-15.53%
Return on Capital Employed (ROCE)	-16.42%
Weighted Average Cost of Capital (WACC)	8.99%
Revenue Per Employee	286.38M
Profits Per Employee	-546.35M
Employee Count	16
Asset Turnover	0.07
Inventory Turnover	0.43

Taxes

In the past 12 months, IDX:MEDS has paid 263.36 million in taxes.

Income Tax	263.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.00% in the last 52 weeks. The beta is 0.89, so IDX:MEDS's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+44.00%
50-Day Moving Average	78.76
200-Day Moving Average	64.99
Relative Strength Index (RSI)	39.85
Average Volume (20 Days)	49,123,885

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IDX:MEDS had revenue of IDR 4.58 billion and -8.74 billion in losses. Loss per share was -5.59.

Revenue	4.58B
Gross Profit	-539.51M
Operating Income	-9.16B
Pretax Income	-8.48B
Net Income	-8.74B
EBITDA	-5.09B
EBIT	-9.16B
Loss Per Share	-5.59

Balance Sheet

The company has 586.55 million in cash and 7.13 billion in debt, with a net cash position of -6.55 billion or -4.19 per share.

Cash & Cash Equivalents	586.55M
Total Debt	7.13B
Net Cash	-6.55B
Net Cash Per Share	-4.19
Equity (Book Value)	50.90B
Book Value Per Share	32.57
Working Capital	10.07B

Cash Flow

In the last 12 months, operating cash flow was -3.13 billion and capital expenditures -165.96 million, giving a free cash flow of -3.30 billion.

Operating Cash Flow	-3.13B
Capital Expenditures	-165.96M
Free Cash Flow	-3.30B
FCF Per Share	-2.11

Margins

Gross margin is -11.77%, with operating and profit margins of -200.01% and -190.78%.

Gross Margin	-11.77%
Operating Margin	-200.01%
Pretax Margin	-185.03%
Profit Margin	-190.78%
EBITDA Margin	-111.14%
EBIT Margin	-200.01%
FCF Margin	n/a

Dividends & Yields

IDX:MEDS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.77%
FCF Yield	-2.93%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IDX:MEDS has an Altman Z-Score of 3.68 and a Piotroski F-Score of 1.

Altman Z-Score	3.68
Piotroski F-Score	1